To compare Sugammadex and Neostigmine for Recovery of postoperative respiratory muscle strength After General Anaesthesia

Comparison of Suggamadex versus Neostigmine for recovery of respiratory muscle strength in patients undergoing General anaesthesia - a one year Randomised Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106159

Enrollment

Registered

2026-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Suggamadex: Sugammadex administered IV at a dose of 2 mg/kg for reversal of aminosteroid neuromuscular blockade(vecuronium) Intervention2: Suggamadex: Patients will be administered Suga

Eligibility

Inclusion criteria

Inclusion criteria: Adults older than 18 years Patients who are ASA physical status I, II, or III Surgery where muscle relaxant drugs will be used Surgery requiring endotracheal intubation Patients who are planned to be extubated in the operating room

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
To compare suggamadex and neostigmine for recovery of respiratory muscle strength by assessing tidal volume using spirometry. Timepoint: 30 mins,60 mins,90 mins,120 mins	—

Secondary

Measure	Time frame
To assess for any complications related to the drug.Timepoint: Baseline(0 mins),30 mins,60 mins,90 mins,120 mins	—

Countries

India

Contacts

Public ContactDr Rajesh S Mane

KLES Dr Prabhakar Kore Hospital and Medical Research Centre

drrajeshmane@gmail.com9844131062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026